A pharmaceuticals health care company.
H.R.4617: Protect Medical Innovation Act. Education about the importance of proper reimbursement for home monitoring services for anticoagulation management.

Education about the regulation of continuous glucose monitor technologies including CMS regulation of CGM. Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act.

Reauthorization of PAHPA (Pandemic All Hazards Preparedness Act).

H.R.6: Support for Patients and Communities Act as it relates to provisions designed to promote the importance of non-pharmacological pain treatment options, including medical devices.
TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX